Related Experiment Video
Updated: Jul 1, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Mechanisms of Local Aggressiveness Without Metastasis in Dermatofibrosarcoma Protuberans
Reed Popp1, Dirk M Elston2, Emmanuel M Gabriel3
1University of Florida College of Medicine, Gainesville, FL, U.S.A.; reedpopp@ufl.edu.
Anticancer Research
|June 29, 2026
Summary
Dermatofibrosarcoma protuberans (DFSP) primarily invades locally. Metastasis is rare and linked to fibrosarcomatous changes, suggesting DFSP is optimized for stromal infiltration, not systemic spread.
Area of Science:
- Oncology
- Dermatology
- Cancer Biology
Background:
- Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer known for aggressive local invasion.
- The reasons for its low metastatic potential despite invasiveness are not fully understood.
Purpose of the Study:
- To review current evidence on DFSP's local invasion, metastasis, and molecular drivers.
- To understand the role of the COL1A1-PDGFB fusion in DFSP pathogenesis.
Main Methods:
- A narrative review of peer-reviewed literature from 2010-2026.
- Focused on clinicopathologic features, fibrosarcomatous transformation, and molecular aspects.
Main Results:
- DFSP infiltrates dermis and subcutis, often exceeding visible margins.
- The COL1A1-PDGFB fusion drives tumor growth but not metastasis; metastasis is more common in fibrosarcomatous DFSP.
- DFSP shows limited lymphovascular invasion and incomplete dissemination mechanisms.
Conclusions:
- DFSP is biologically geared towards local invasion rather than metastasis.
- Metastatic potential arises from additional molecular/microenvironmental changes, especially in fibrosarcomatous variants.
- Further research on stromal interactions and vascular access is needed.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

